drugset / Trial / NCT06381557

Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules

NCT06381557 ↗

Phase 4 Not yet recruiting 240 enrolled Qiang Fu Yangtze River Pharmaceutical Group Co., Ltd. · collab
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

Traditional Chinese medicine(TCM) has achieved some meaningful results in improving the symptoms and quality of life of cancer patients, but many research results need to be further verified by clinical trials with larger samples and better design.This study aims to investigate effectiveness and safety of Zhengyuan Capsules for cancer-related fatigue in patients with breast cancer.

Timeline

Start
2024-05-01
Primary completion
2027-03-01
Completion
2027-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Zhengyuan Capsules Unknown 4 unknown —

Indications

No indication recorded.